InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Rankin Aubrey. Insider active across 1 company, notably Revance Therapeutics, Inc.. In total, 5 filings have been logged. Split: 1 buy · 2 sells. Total volume traded: €2.6m. History available since 26 July 2021. The latest transaction was filed on 15 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rankin Aubrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,372 shares@ US$15.790.7% of flowCommon StockSEC:0001209191-22-019718:0
30,000 shares@ US$14.429213.8% of flowCommon StockSEC:0001479290-21-000171:0
Canonical exit: 3 Mar 2022 (T+90)
4,949 shares@ US$26.023.9% of flowCommon StockSEC:0001479290-21-000152:0
34,332 shares@ US$30.0031.3% of flowCommon StockSEC:0001479290-21-000141:0
55,382 shares@ US$29.7250.2% of flowCommon StockSEC:0001479290-21-000139:0
5 of 5 declarations
About Rankin Aubrey
Rankin Aubrey is a director at Revance Therapeutics, Inc.
